Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4583677
Max Phase: Preclinical
Molecular Formula: C32H28Cl2F3N7O6
Molecular Weight: 620.50
Molecule Type: Unknown
Associated Items:
ID: ALA4583677
Max Phase: Preclinical
Molecular Formula: C32H28Cl2F3N7O6
Molecular Weight: 620.50
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN(C)C/C=C/C(=O)Nc1ccc(C(=O)Nc2ccc(NC(=O)c3n[nH]cc3NC(=O)c3c(Cl)cccc3Cl)cc2)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C30H27Cl2N7O4.C2HF3O2/c1-39(2)16-4-7-25(40)34-19-10-8-18(9-11-19)28(41)35-20-12-14-21(15-13-20)36-30(43)27-24(17-33-38-27)37-29(42)26-22(31)5-3-6-23(26)32;3-2(4,5)1(6)7/h3-15,17H,16H2,1-2H3,(H,33,38)(H,34,40)(H,35,41)(H,36,43)(H,37,42);(H,6,7)/b7-4+;
Standard InChI Key: NOTZURHXMDETAL-KQGICBIGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 620.50 | Molecular Weight (Monoisotopic): 619.1502 | AlogP: 5.53 | #Rotatable Bonds: 10 |
Polar Surface Area: 148.32 | Molecular Species: BASE | HBA: 6 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.30 | CX Basic pKa: 8.69 | CX LogP: 4.57 | CX LogD: 3.53 |
Aromatic Rings: 4 | Heavy Atoms: 43 | QED Weighted: 0.15 | Np Likeness Score: -1.15 |
1. Ferguson FM, Doctor ZM, Ficarro SB, Marto JA, Kim ND, Sim T, Gray NS.. (2019) Synthesis and structure activity relationships of a series of 4-amino-1H-pyrazoles as covalent inhibitors of CDK14., 29 (15): [PMID:31175010] [10.1016/j.bmcl.2019.05.024] |
Source(1):